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Abstract
Aims—Second opinions in pathology improve patient safety by reducing diagnostic errors, 
leading to more appropriate clinical treatment decisions. Little objective data are available 
regarding the factors triggering a request for second opinion despite second opinion consultations 
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being part of the diagnostic system of pathology. Therefore we sought to assess breast biopsy 
cases and interpreting pathologists characteristics associated with second opinion requests.
Methods—Collected pathologist surveys and their interpretations of 60 test set cases were used 
to explore the relationships between case characteristics, pathologist characteristics and case 
perceptions, and requests for second opinions. Data were evaluated by logistic regression and 
generalised estimating equations.
Results—115 pathologists provided 6900 assessments; pathologists requested second opinions 
on 70% (4827/6900) of their assessments 36% (1731/4827) of these would not have been required 
by policy. All associations between case characteristics and requesting second opinions were 
statistically significant, including diagnostic category, breast density, biopsy type, and number of 
diagnoses noted per case. Exclusive of institutional policies, pathologists wanted second opinions 
most frequently for atypia (66%) and least frequently for invasive cancer (20%). Second opinion 
rates were higher when the pathologist had lower assessment confidence, in cases with higher 
perceived difficulty, and cases with borderline diagnoses.
Conclusions—Pathologists request second opinions for challenging cases, particularly those 
with atypia, high breast density, core needle biopsies, or many co-existing diagnoses. Further 
studies should evaluate whether the case characteristics identified in this study could be used as 
clinical criteria to prompt system-level strategies for mandating second opinions.
BACKGROUND
Second opinions in pathology improve patient safety by reducing diagnostic errors, leading 
to more appropriate clinical treatment decisions.12 Pathologists frequently request second 
opinions for pathological interpretations of breast specimens, particularly for new cancer 
diagnoses and when surgery is performed at referral hospitals.3–7 In a recent survey of US 
pathologists participating in the Breast Pathology Study (B-Path), 81% of respondents 
reported obtaining second opinions in their clinical practice on at least some breast 
pathology cases that did not require second opinions due to mandated institutional policies.8 
The vast majority of surveyed pathologists also agreed that second opinions improve their 
diagnostic accuracy and protect them from malpractice suits. Few objective data are 
available regarding the factors triggering a request for second opinion despite second 
opinion consultations being part of the diagnostic system of pathology.9 Additional data 
from practicing pathologists may inform system-level future policy.
The purpose of this study was to determine whether specific characteristics of breast biopsy 
cases were associated with requesting second opinions, and how these associations varied by 
specific diagnoses. In addition, we explored the relationship between requesting a second 
opinion and pathologists’ perceptions of the case, including confidence in their assessment, 
whether they considered a case difficult, and whether they considered a case borderline 
between two diagnoses. Finally, we compared the association between these variables and 
whether the request for second opinion was based on institutional policy or desired for 
diagnostic reasons regardless of policy.
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METHODS
This observational cross-sectional study is part of the larger B-Path Study,10–12 which was 
designed to evaluate diagnostic variation in the interpretation of breast biopsies among 
practicing pathologists. Two hundred and forty breast specimens were randomly selected 
from two state pathology registries (NH, VT) that are part of the National Cancer Institute 
sponsored Breast Cancer Surveillance Consortium.13 Selection was stratified by age (49% 
age 40–49 years, 51% age ≥50 years), breast density (51% with heterogeneously or 
extremely dense breast tissue based on mammography), and biopsy type (58% core needle, 
42% excisional). The cases were divided into four test sets of 60 cases as described in a 
previous publication.10 Each case was represented by one glass slide, which was carefully 
checked for quality. Participants were instructed to assume that the single slide demonstrated 
the best diagnostic features of the case.
Participating pathologists
Pathologists from eight US states (Alaska, Maine, Minnesota, New Hampshire, New 
Mexico, Oregon, Vermont and Washington) were invited to participate. Details of their 
identification and recruitment have been described elsewhere.1014 Participating pathologists 
completed a web-based survey followed by interpreting their assigned test set of 60 cases.
Physician survey
Pathologists self-reported demographic and clinical practice characteristics, including age, 
gender, expertise in breast pathology, professional and academic affiliations, fellowship 
training in surgical and breast pathology, number of years interpreting breast pathology, and 
proportion of caseload devoted to breast specimens.
Diagnostic histology data collection
Participants completed an online histology data collection form10 for each case, and were 
asked to interpret the cases using the same diagnostic criteria they would use in regular 
clinical practice. We categorised their interpretations on each case into one of four primary 
diagnostic categories (benign without atypia, atypia (atypical ductal hyperplasia (ADH) or 
ADH in a papilloma), ductal carcinoma in situ (DCIS), and invasive carcinoma) as detailed 
elsewhere.10 There were 14 unique possible diagnoses comprising the four primary 
diagnostic categories; we calculated the sum of total unique diagnoses used for each case to 
create a cumulative diagnosis value as a surrogate measure of case complexity. The 
histology form also asked pathologists if they considered the case borderline between two 
diagnoses. Pathologists rated their perceived levels of diagnostic challenge and their 
confidence in their diagnosis for each test case. A six-point Likert scale ranging from 1 
(‘very easy’) to 6 (‘very challenging’) was provided for the question ‘Rate your opinion of 
the level of diagnostic difficulty of this case’, and a six-point Likert scale from 1 (‘very 
confident’) to 6 (‘not confident at all’) was used to rate confidence in their assessment. 
Likert responses were collapsed into binary outcomes: ‘low degree of challenge’ (Likert 1, 
2, 3) versus ‘high degree of challenge’ (Likert 4, 5, 6); and ‘high confidence’ (Likert 1, 2, 3) 
versus ‘low confidence’ (Likert 4, 5, 6).
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Finally, pathologists recorded whether they would have asked for a second pathologist’s 
opinion of the case before finalising the report if they were interpreting the case in clinical 
practice. They could choose from the following responses: (1) Yes, I would want a second 
pathologist’s opinion for diagnostic reasons; (2) Yes, because it is our policy to get a second 
opinion in cases with this diagnosis; (3) Yes, I would want a second pathologist’s opinion 
for diagnostic reasons and yes, because it is our policy to get a second opinion in cases with 
this diagnosis (ie, both response 1 and 2 were checked); and (4) No, I do not want a second 
opinion.
Case characteristics
The woman’s age at the time of biopsy and biopsy type were available to the pathologists for 
each case. The registry provided patient age, while biopsy type was determined by review of 
the original case slides and pathology report. Radiologists provided mammographic breast 
density according to the BIRADS mammographic density classifications. For analysis, we 
dichotomised mammographic density to high (very dense or heterogeneously dense) and low 
(scattered fibroglandular densities or almost entirely fat).
Statistical analysis
Frequencies and percentages for each of four response categories for second opinions were 
calculated. Associations between the dependent variable, request for second opinion, and 
pathologist and case characteristics (including diagnostic category) as single covariates were 
tested using repeated measures logistic regression with and without adjustment under PROC 
GENMOD in SAS software. To assess the impact these characteristics had on the dependent 
variable, responses to the request for a second opinion were dichotomised by grouping all 
three affirmative responses together as ‘Yes’ compared with ‘No, I do not want a second 
opinion’. Second opinion rates were calculated using a generalised estimating equation 
(GEE) with a binomial distribution and independent correlation structure, accounting for 
clustered responses within each participant. Estimates and SEs of least square (LS) means 
were computed and transformed back to the original response scale via the inverse-link 
function to provide rates of second opinion and their 95% CIs. An additional sensitivity 
analysis was conducted for the dichotomous outcome of requesting a second opinion after 
removing second opinion requests that were based on policy alone. Wald-based p values and 
95% CIs were computed using a two-sided significance level of 0.05. Statistical analyses 
were performed using SAS software V.9.4 for the Windows Operating System (SAS Institute 
Inc, Cary, North Carolina, USA).
RESULTS
One hundred and fifteen pathologists completed the survey and each reviewed 60 breast 
biopsy cases that included more cases of ADH and DCIS than in clinical practice. Among 
the 6900 independent case assessments, pathologists reported that they would request a 
second opinion (either as required by policy and/or desired by the pathologist) for 70% 
(4827/6900). Of cases for which the pathologists requested a second opinion, just over one-
third (36%; 1731/4827) would not have been required by laboratory policies in their clinical 
practices (table 1).
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Only two pathologists’ characteristics were statistically significantly associated with 
requesting second opinions. Requesting second opinions occurred less frequently for 
pathologists with academic medical centre affiliations (60% vs 73%, p = 0.021) and among 
pathologists considered experts in breast pathology by their peers (56% vs 74%, p = 0.003) 
compared with pathologists without these characteristics (table 1).
All of the case characteristics evaluated were significantly associated with whether or not a 
second opinion was requested (table 2).
Cases in which women had high versus low mammographic breast density (72% vs 68%; 
p≥0.001) were more likely to have a second opinion requested. Cases from core needle 
biopsies compared with excisional biopsies (72% vs 67%; p = 0.006), and cases with 
increasing cumulative unique diagnoses as indicated by the pathologists who interpreted the 
cases (<4 (64%), 4–7 (70%) and ≥8 (74%); p≤0.001) were also associated with more 
frequent requests for second opinions.
Pathologists were more likely to request second opinions for cases they considered 
challenging (94%), had low confidence in their assessments (94%), or considered borderline 
(95%), regardless of whether their decisions were based on policy and/ or for diagnostic 
reasons (all p≤0.001) (table 2). Pathologists requested a second opinion for diagnostic 
reasons alone for 50% of the cases when they considered them challenging or when 
confidence in their assessment was low, and 53% when they considered the case borderline 
between two diagnoses.
Figure 1 shows the reasons pathologists requested second opinions for each of the cases 
interpreted, according to the diagnosis that they indicated for the case. The most frequent 
request for a second opinion for either policy and/or diagnostic reasons was for cases of 
atypia; pathologists requested a second opinion on 88% of all cases that they interpreted as 
atypia. Atypia was the most frequent diagnosis for which a second opinion was desired for 
personal diagnostic reasons (66% of all cases interpreted as atypia). In contrast, pathologists 
were least likely to request a second opinion for diagnostic reasons for cases of invasive 
carcinoma (20% of all invasive cases). However, as expected, invasive carcinoma was the 
most common diagnostic category for which pathologists noted that a second opinion would 
be required by policy in their own practices (60% of all invasive cases).
To better understand how perceptions of a case and diagnostic categories were related to the 
second opinion requests for diagnostic reasons (and not for policy reasons) we used a 
comparison group combining the responses ‘No, I don’t want a second opinion’ and ‘Yes, I 
want a second opinion because it is a policy’ (left side of figure 2 and see online 
supplementary table S1). Pathologists’ perception of a case mattered when they checked off 
whether or not they desired a second opinion for diagnostic reasons. Pathologists were 
significantly more likely to want a second opinion when they had low confidence in their 
assessment, when the case was perceived as challenging, or when it was considered 
borderline (p<0.001). These statistically significant differences were noted regardless of the 
pathologists’ diagnosis of the case. The atypia diagnosis category was distinct from the other 
three diagnostic categories; pathologists desired a second opinion for more than 50% of the 
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cases they interpreted as atypia even when the pathologist was confident, ranked the case a 
low degree of challenge, and did not consider it borderline. The most frequent request for a 
second opinion for diagnostic reasons was for invasive cancer that was considered borderline 
(82%, CI 69% to 90%); the most frequent alternative diagnoses selected for these borderline 
cases were DCIS (60%), sclerosing adenosis (19%) and radial scar (17%). The least frequent 
request for a second opinion was for invasive cases in which the case was ranked low in 
degree of challenge (12%, CI 8% to 17%).
When comparing interpretations for which a second opinion was desired for diagnostic 
reasons with those for which a second opinion was not desired (excluding from the analysis 
second opinions indicated only due to policy), comparison of rates of second opinions was 
statistically significantly associated only with cases considered borderline across all 
diagnostic categories (right side of figure 2; p = 0.005). When the pathologists’ confidence 
in the assessment was low, pathologists desired a second opinion most frequently for the 
diagnosis of atypia (96%, CI 92% to 98%) and invasive cancer (96%, CI 77% to 99%) (see 
online supplementary table S2). However, pathologists desired second opinions for over 
67% of cases (data not shown) of atypia despite feeling confident in their diagnoses, 
indicating the case was easy, and noting that the case was not borderline.
DISCUSSION
In this study of interpretations of breast biopsy cases, pathologists indicated frequent 
requests for second opinions when they were less confident in their assessments, found the 
case challenging, and identified the case as borderline, even when their laboratory policies 
did not require second opinions. As expected, pathologists affiliated with academic medical 
centres or considered experts in breast pathology by their peers were less likely to request 
second opinions than pathologists without these characteristics. However, characteristics of 
the case, rather than the pathologist, were more often associated with requests for second 
opinions.
The diagnosis of breast epithelial atypia (ADH and ADH in a papilloma) had the highest rate 
of second opinion requests by the participating pathologist within the four diagnostic 
categories evaluated. Notably, these requests were observed regardless of the pathologists’ 
confidence in assessment, diagnostic challenge of the case, or presence of borderline 
diagnostic features. When we excluded cases where the pathologist indicated the only reason 
for a second opinion was a laboratory policy, the rates for second opinion requests increased 
in all diagnostic categories. As expected, rates were high (86–96%) when pathologists 
indicated they were not confident in the diagnosis, the case was challenging, or the case was 
borderline between two categories. In contrast to the other diagnostic categories, cases with 
atypia had high rates of second opinion requests (67–78%) even when pathologists indicated 
they were confident, the case was easier, and the case did not have borderline features.
These findings suggest that pathologists frequently desire and likely obtain second opinions 
in clinical practice, particularly for cases with atypia. Considering the low diagnostic 
agreement rates for atypia that have been reported,10 diagnostic accuracy might be improved 
if second opinions were obtained for all cases with atypia. More widespread adoption of 
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second opinion policies and guidelines may improve diagnostic accuracy and provide the 
support that practicing pathologists seem to want.
A decade ago, an external review of the UK National Health Service Breast Screening 
Programme (NHSBSP) reported several areas in breast pathology that could be improved but 
concluded that the diagnosis of atypical hyperplasia, which they found to have very poor 
concordance, cannot be improved.15 In the evaluation of the NHSBSP they noted that the 
diagnostic criteria for atypical hyperplasia, which at that time had been recently updated, did 
not improve the diagnosis and they did not recommend any other avenues for improvement. 
However, others have suggested that obtaining second opinions on these challenging cases 
might improve accuracy.16
Increased mammographic breast density was associated with higher rates of requests for 
second opinions in the present study, as well as with lower diagnostic agreement among 
pathologists in a prior B-Path Study.10 Breast density is primarily attributable to fibrous 
tissue of the breast.17–19 However, breast fibrosis is not a factor considered in the diagnosis 
of epithelial proliferations pathologically. To further explore the potential effect of density, 
we also evaluated whether the spectrum of epithelial proliferation present in a case might be 
associated with increased requests for second opinion and noted that requests increased for 
cases with higher cumulative unique diagnoses attributed to the case by the multiple 
pathologists who independently interpreted the case. Thus, we hypothesise that epithelial 
breast complexity, by inference, is associated with breast density.
This work presents new findings of the B-Path Study, which was originally designed to 
evaluate diagnostic variation in the interpretation of breast biopsies among practicing 
pathologists by collecting data related to diagnostic accuracy. The present study describes in 
detail pathologists’ desires for second opinion when interpreting breast biopsy cases and 
evaluates whether intrinsic features of the breast biopsy specimen and characteristics of 
pathologists were associated with pathologists’ requests for consultative second opinions. To 
our knowledge, this is the first study to examine these associations of case and pathologists’ 
characteristics with obtaining second opinions. Most studies examining the use of second 
opinions focus on changes in histological diagnoses3–720 and do not report the pathologists’ 
underlying perceptions of the case or characteristics associated with cases where they desire 
second opinions. Although some studies have reported case characteristics, such as 
diagnoses and oestrogen-progesterone receptors and HER2 status, none have related them to 
the use of second opinion.1520
The strengths of this study include the participation of a large number of practicing 
pathologists (N = 115) from across the US, each interpreting 60 cases and providing 
independent diagnostic assessments and their perceptions regarding challenges in 
interpreting these cases. These data were then linked to pathologist demographic and clinical 
practice characteristics and case characteristics. The results of this study could guide 
educational interventions for practicing pathologists and trainees, as well as inform policy 
changes to improve diagnostic systems by establishing system-level strategies for when 
second opinions should be obtained.
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There are several limitations to this study. While this study used a single slide to improve 
efficiency and enhance participation of practicing pathologists, it does not replicate clinical 
practice, where the initial pathologist evaluating a case may have access to additional slides 
or special stains and the option to consult with other pathologists. Interpreting cases in this 
situation, especially when the cases included more atypia and DCIS than typically observed 
in clinical practice, may also alter interpretive performance. This may have led to more 
assessments rated as challenging.
CONCLUSIONS
In conclusion, breast biopsies are challenging to interpret10 and likely lead to frequent 
second opinions in clinical practice regardless of institutional policy.8 Clinical systems may 
need to be optimised to support pathologists and their desires for the use of second opinions. 
In addition, broader reimbursement may be needed for second opinion if future research 
shows that second opinions lead to improvements in clinical care. We identified breast 
biopsy case characteristics that are strongly associated with whether practicing pathologists 
desire second opinions. Pathologists frequently request second opinions for challenging 
cases, particularly for cases with atypia, high breast density, core needle biopsies, or many 
co-existing diagnoses. Further studies should evaluate whether the case characteristics 
identified in this study could be used as clinical criteria to prompt second opinions. The 
ultimate goal of these efforts is to improve support for practicing pathologists, laboratory 
efficiency, and outcomes for patients.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Take home messages
▸ Breast biopsy case characteristics such as patient age, core needle biopsy and 
dense mammographic breast tissue were significantly associated with 
requests for a second opinion.
▸ Pathologists frequently requested second opinions when they were less 
confident in their assessments, found the case challenging, and/or identified 
the case as borderline between two diagnostic categories, even when their 
laboratory policies did not require second opinions.
▸ Second opinions were most frequently requested for diagnoses of atypical 
ductal hyperplasia.
▸ Adoption of broader second opinion guidelines and policies may improve 
diagnostic accuracy and provide the support that practicing pathologists seem 
to desire.
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Figure 1. 
Requests for second opinion by participating pathologists’ diagnostic categories.
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Figure 2. 
Proportion of second opinions requested for the test set cases by case-level pathologists’ 
perceptions and their diagnostic categories.
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ps
y 
ty
pe
 w
er
e 
pr
ov
id
ed
 to
 p
ar
tic
ip
an
ts 
du
rin
g 
sp
ec
im
en
 a
ss
es
sm
en
t; 
br
ea
st 
de
ns
ity
 w
as
 n
o
t p
ro
v
id
ed
.
¶ L
ow
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en
sit
y 
(≤
50
 fib
ro
gl
an
du
la
r; 
BI
RA
D
S 
ca
te
go
ry
 1
 a
nd
 2
) a
nd
 hi
gh
 de
ns
ity
 (≤
51
% 
fib
ro
gl
an
du
la
r; 
BI
RA
D
S 
ca
te
go
ry
 3
 a
nd
 4
; b
re
as
t d
en
sit
y 
w
as
 n
o
t p
ro
v
id
ed
 to
 p
ar
tic
ip
an
ts 
du
rin
g 
sp
ec
im
en
 
as
se
ss
m
en
t).
*
*
N
um
be
r o
f u
ni
qu
e 
di
ag
no
sti
c 
su
bt
yp
es
 a
t t
he
 le
v
el
 o
f e
ac
h 
ca
se
 a
s d
et
er
m
in
ed
 b
y 
pa
rti
ci
pa
nt
s.
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CI
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